scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1349-7006.1999.TB00763.X |
P8608 | Fatcat ID | release_4tuwpvxlmfaefkbbnwt2xpdvuq |
P932 | PMC publication ID | 5926086 |
P698 | PubMed publication ID | 10363579 |
P5875 | ResearchGate publication ID | 12934591 |
P2093 | author name string | S Matsumoto | |
M Koyama | |||
J Fujimoto | |||
T Shiba | |||
M Emi | |||
H Nagai | |||
T Tajiri | |||
N Konishi | |||
T Ueki | |||
M Onda | |||
N Kawamura | |||
K Bando | |||
P2860 | cites work | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
Antioncogenes and human cancer | Q28237050 | ||
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity | Q28284646 | ||
Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma | Q28287494 | ||
The 1993-94 Généthon human genetic linkage map | Q28288492 | ||
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome | Q29615538 | ||
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma | Q33493133 | ||
Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma | Q33772796 | ||
Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma | Q34319319 | ||
Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22 | Q36115913 | ||
Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma | Q43037073 | ||
Allelotype study of primary hepatocellular carcinoma | Q43578355 | ||
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas | Q48045473 | ||
Germline mutations in PTEN are present in Bannayan-Zonana syndrome | Q48046915 | ||
Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles | Q48379390 | ||
PTEN/MMAC1 mutations in endometrial cancers. | Q53439663 | ||
Comprehensive allelotyping of human hepatocellular carcinoma | Q57981015 | ||
Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer | Q67885643 | ||
Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer | Q68159719 | ||
Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas | Q69927567 | ||
Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas | Q72685147 | ||
Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma | Q72970952 | ||
Allelotype analysis of hepatocellular carcinoma | Q74029725 | ||
Five familial hypercholesterolemic kindreds in Japan with novel mutations of the LDL receptor gene | Q77680094 | ||
P433 | issue | 4 | |
P1104 | number of pages | 6 | |
P304 | page(s) | 413-418 | |
P577 | publication date | 1999-04-01 | |
P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
P1476 | title | PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors | |
P478 | volume | 90 |
Q38490789 | Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines. |
Q81811800 | Correlation between loss of PTEN expression and PKB/AKT phosphorylation in hepatocellular carcinoma |
Q39656536 | Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2. |
Q43141122 | Expression of phosphatase and tensin homolog deleted on chromosome ten in liver of athymic mice with hepatocellular carcinoma and the effect of Fuzheng Jiedu Decoction |
Q28204251 | FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer |
Q34611410 | Genetic mechanisms of hepatocarcinogenesis |
Q48368105 | Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis |
Q54503350 | Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma. |
Q84403214 | Molecular classification of hepatocellular carcinoma |
Q36862768 | Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response |
Q92316075 | PTEN Tumor-Suppressor: The Dam of Stemness in Cancer |
Q39377876 | PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma. |
Q34966603 | Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging |
Q33392970 | Sequencing the full-length of the phosphatase and tensin homolog (PTEN) gene in hepatocellular carcinoma (HCC) using the 454 GS20 and Illumina GA DNA sequencing platforms |
Q27002288 | Targeted therapy for hepatocellular carcinoma: novel agents on the horizon |
Q38635474 | The biology of Hepatocellular carcinoma: implications for genomic and immune therapies |
Q29547860 | The phosphatidylinositol 3-Kinase AKT pathway in human cancer |
Q24657943 | The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma |